Nerve injury evoked loss of latexin expression in spinal cord neurons contributes to the development of neuropathic pain

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Kühlein, Hilmar Nils ^a   Tegeder, Irmgard ^a   Möser, Christine ^a   Lim, Hee Young ^a   Häussler, Annett ^a   Spieth, Katharina ^a   Jennes, Ingo ^b   Marschalek, Rolf ^b   Beckhaus, Tobias ^b   Karas, Michael ^b   Fauth, Markus ^b   Ehnert, Corina ^a   Geisslinger, Gerd ^a   Niederberger, Ellen ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE A; LATEXIN; PEPTIDE HYDROLASE INHIBITOR; UNCLASSIFIED DRUG; ANTIGEN; BENZYLSUCCINIC ACID; PC3.1 ANTIGEN; SUCCINIC ACID DERIVATIVE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE INJURY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; SENSORY NERVE CELL; SPINAL CORD DORSAL HORN; SPINAL CORD MOTONEURON; SPINAL CORD NERVE CELL; SPINAL GANGLION; WESTERN BLOTTING; ADENOVIRUS; ANIMAL; C57BL MOUSE; COLD; CYTOLOGY; DRUG ANTAGONISM; GENETICS; HYPERALGESIA; INJURY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOUSE; NERVE CELL; NEURALGIA; PATHOPHYSIOLOGY; SCIATIC NEUROPATHY; SPINAL CORD; SPRAGUE DAWLEY RAT; SURAL NERVE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENOVIRIDAE; ANIMALS; ANTIGENS; BLOTTING, WESTERN; CARBOXYPEPTIDASES A; COLD TEMPERATURE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HYPERALGESIA; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; NEURALGIA; NEURONS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCIATIC NERVE; SCIATIC NEUROPATHY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPINAL CORD; SUCCINATES; SURAL NERVE;

EID: 79955772057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019270     Document Type: Article

References (38)

1. Woolf CJ, Mannion RJ, (1999) Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353: 1959-1964.
2. Sindrup SH, Jensen TS, (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83: 389-400.
3. Dray A, (2008) Neuropathic pain: emerging treatments. Br J Anaesth 101: 48-58.
4. O'Connor AB, Dworkin RH, (2009) Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 122: S22-32.
5. Niederberger E, Geisslinger G, (2008) Proteomics in neuropathic pain research. Anesthesiology 108: 314-323.
6. Decosterd I, Woolf CJ, (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87: 149-158.
7. Normant E, Martres MP, Schwartz JC, Gros C, (1995) Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proc Natl Acad Sci U S A 92: 12225-12229.
8. Pallares I, Bonet R, Garcia-Castellanos R, Ventura S, Aviles FX, et al. (2005) Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc Natl Acad Sci U S A 102: 3978-3983.
9. Krondahl E, Von Euler-Chelpin H, Orzechowski A, Ekstrom G, Lennernas H, (2000) Investigations of the in-vitro metabolism of three opioid tetrapeptides by pancreatic and intestinal enzymes. J Pharm Pharmacol 52: 785-795.
10. Miller LA, Cochrane DE, Feldberg RS, Carraway RE, (1998) Inhibition of neurotensin-stimulated mast cell secretion and carboxypeptidase A activity by the peptide inhibitor of carboxypeptidase A and neurotensin-receptor antagonist SR 48692. Int Arch Allergy Immunol 116: 147-153.
11. Bradbury AF, Smyth DG, Snell CR, (1976) Prohormones of beta-melanotropin (beta-melanocyte-stimulating hormone, beta-MSH) and corticotropin (adrenocorticotropic hormone, ACTH): structure and activation. Ciba Found Symp 41: 61-75.
12. Lundequist A, Tchougounova E, Abrink M, Pejler G, (2004) Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II. J Biol Chem 279: 32339-32344.
13. Kieffer BL, Gaveriaux-Ruff C, (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66: 285-306.
14. Takiguchi-Hayashi K, Sato M, Sugo N, Ishida M, Sato K, et al. (1998) Latexin expression in smaller diameter primary sensory neurons in the rat. Brain Res 801: 9-20.
15. Jin M, Ishida M, Katoh-Fukui Y, Tsuchiya R, Higashinakagawa T, et al. (2006) Reduced pain sensitivity in mice lacking latexin, an inhibitor of metallocarboxypeptidases. Brain Res 1075: 117-121.
16. Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, et al. (2006) GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12: 1269-1277.
17. Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P, (1992) In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 203: 173-179.
18. Corvey C, Koetter P, Beckhaus T, Hack J, Hofmann S, et al. (2005) Carbon Source-dependent assembly of the Snf1p kinase complex in Candida albicans. J Biol Chem 280: 25323-25330.
19. Brown KS, Kingsbury WD, Hall NM, Dunn GL, Gilvarg C, (1987) Determination of carboxypeptidase A using N-acetyl-phenylalanyl-3-thiaphenylalanine as substrate: application to a direct serum assay. Anal Biochem 161: 219-225.
20. Stewart JD, Gilvarg C, (2000) Determination of serum procarboxypeptidase A concentrations in healthy human adults. Clin Chim Acta 292: 107-115.
21. Matsugi S, Hamada T, Shioi N, Tanaka T, Kumada T, et al. (2007) Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. Clin Chim Acta 378: 147-153.
22. Chomczynski P, (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-534, 536-537.
23. Kugler S, Meyn L, Holzmuller H, Gerhardt E, Isenmann S, et al. (2001) Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors. Mol Cell Neurosci 17: 78-96.
24. Kugler S, Kilic E, Bahr M, (2003) Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther 10: 337-347.
25. Byers LD, Wolfenden R, (1972) A potent reversible inhibitor of carboxypeptidase A. J Biol Chem 247: 606-608.
26. Hatanaka Y, Uratani Y, Takiguchi-Hayashi K, Omori A, Sato K, et al. (1994) Intracortical regionality represented by specific transcription for a novel protein, latexin. Eur J Neurosci 6: 973-982.
27. Takiguchi-Hayashi K, (2001) In vitro clonal analysis of rat cerebral cortical neurons expressing latexin, a subtype-specific molecular marker of glutamatergic neurons. Brain Res Dev Brain Res 132: 87-90.
28. Griffin RS, Costigan M, Brenner GJ, Ma CH, Scholz J, et al. (2007) Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J Neurosci 27: 8699-8708.
29. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, et al. (2008) Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14: 331-336.
30. Clark AK, Yip PK, Grist J, Gentry C, Staniland AA, et al. (2007) Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci U S A 104: 10655-10660.
31. Bai WZ, Ishida M, Arimatsu Y, (2004) Chemically defined feedback connections from infragranular layers of sensory association cortices in the rat. Neuroscience 123: 257-267.
32. Goldstein SM, Leong J, Bunnett NW, (1991) Human mast cell proteases hydrolyze neurotensin, kinetensin and Leu5-enkephalin. Peptides 12: 995-1000.
33. Schneider LA, Schlenner SM, Feyerabend TB, Wunderlin M, Rodewald HR, (2007) Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med 204: 2629-2639.
34. Khodorova A, Montmayeur JP, Strichartz G, (2009) Endothelin receptors and pain. J Pain 10: 4-28.
35. Wang JY, Zhao M, Huang FS, Tang JS, Yuan YK, (2008) Mu-opioid receptor in the nucleus submedius: involvement in opioid-induced inhibition of mirror-image allodynia in a rat model of neuropathic pain. Neurochem Res 33: 2134-2141.
36. Takiguchi-Hayashi K, Arimatsu Y, (1995) Restricted expression of latexin in dorsal midline cells of developing rat forebrain. Neuroreport 6: 281-283.
37. Lyons PJ, Fricker LD, (2010) Substrate specificity of human carboxypeptidase A6. J Biol Chem 285: 38234-38242.
38. Arimatsu Y, Kojima M, Ishida M, (1999) Area- and lamina-specific organization of a neuronal subpopulation defined by expression of latexin in the rat cerebral cortex. Neuroscience 88: 93-105.